Cargando…

MicroRNAs as Key Players in Melanoma Cell Resistance to MAPK and Immune Checkpoint Inhibitors

Advances in the use of targeted and immune therapies have revolutionized the clinical management of melanoma patients, prolonging significantly their overall and progression-free survival. However, both targeted and immune therapies suffer limitations due to genetic mutations and epigenetic modifica...

Descripción completa

Detalles Bibliográficos
Autores principales:	Motti, Maria Letizia, Minopoli, Michele, Di Carluccio, Gioconda, Ascierto, Paolo Antonio, Carriero, Maria Vincenza
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7352536/ https://www.ncbi.nlm.nih.gov/pubmed/32604720 http://dx.doi.org/10.3390/ijms21124544

Ejemplares similares

Therapeutic Strategies Targeting Urokinase and Its Receptor in Cancer
por: Masucci, Maria Teresa, et al.
Publicado: (2022)

Emerging Targeted Therapeutic Strategies to Overcome Imatinib Resistance of Gastrointestinal Stromal Tumors
por: Masucci, Maria Teresa, et al.
Publicado: (2023)

Cyclization of the Urokinase Receptor-Derived Ser-Arg-Ser-Arg-Tyr Peptide Generates a Potent Inhibitor of Trans-Endothelial Migration of Monocytes
por: Yousif, Ali Munaim, et al.
Publicado: (2015)

Effect of ABT-888 on the apoptosis, motility and invasiveness of BRAFi-resistant melanoma cells
por: Fratangelo, Federica, et al.
Publicado: (2018)

Role of Microenvironment on the Fate of Disseminating Cancer Stem Cells
por: Ingangi, Vincenzo, et al.
Publicado: (2019)

Targeting the cross-talk between Urokinase receptor and Formyl peptide receptor type 1 to prevent invasion and trans-endothelial migration of melanoma cells
por: Ragone, Concetta, et al.
Publicado: (2017)

Controversial Role of Kisspeptins/KiSS-1R Signaling System in Tumor Development
por: Fratangelo, Federica, et al.
Publicado: (2018)

Oncogenic MicroRNAs: Key Players in Malignant Transformation
por: Frixa, Tania, et al.
Publicado: (2015)

Tumor Associated Neutrophils. Their Role in Tumorigenesis, Metastasis, Prognosis and Therapy
por: Masucci, Maria Teresa, et al.
Publicado: (2019)

AurkA inhibitors enhance the effects of B-RAF and MEK inhibitors in melanoma treatment
por: Caputo, Emilia, et al.
Publicado: (2014)

microRNAs: Key Players in Plant Response to Metal Toxicity
por: Yang, Ying, et al.
Publicado: (2022)

Key questions about the checkpoint blockade-are microRNAs an answer?
por: Dragomir, Mihnea, et al.
Publicado: (2018)

Inhibiting Monocyte Recruitment to Prevent the Pro-Tumoral Activity of Tumor-Associated Macrophages in Chondrosarcoma
por: Minopoli, Michele, et al.
Publicado: (2020)

miRNAs as Key Players in the Management of Cutaneous Melanoma
por: Lorusso, Celeste, et al.
Publicado: (2020)

Extracellular microRNAs: key players to explore the outcomes of in vitro fertilization
por: Khan, Haroon Latif, et al.
Publicado: (2021)

MicroRNAs in melanoma development and resistance to target therapy
por: Fattore, Luigi, et al.
Publicado: (2017)

The Emerging Role of Neutrophil Extracellular Traps (NETs) in Tumor Progression and Metastasis
por: Masucci, Maria Teresa, et al.
Publicado: (2020)

Retro-inverso Urokinase Receptor Antagonists for the Treatment of Metastatic Sarcomas
por: Carriero, Maria Vincenza, et al.
Publicado: (2017)

MicroRNAs: key players of taxane resistance and their therapeutic potential in human cancers
por: Cui, Shi-Yun, et al.
Publicado: (2013)

Skeletal Muscle MicroRNAs as Key Players in the Pathogenesis of Amyotrophic Lateral Sclerosis
por: Di Pietro, Lorena, et al.
Publicado: (2018)

Targeting the Formyl Peptide Receptor type 1 to prevent the adhesion of ovarian cancer cells onto mesothelium and subsequent invasion
por: Minopoli, Michele, et al.
Publicado: (2019)

MicroRNAs: new players in IBD
por: Kalla, R, et al.
Publicado: (2015)

MicroRNAs: Small but Key Players in Viral Infections and Immune Responses to Viral Pathogens
por: Bauer, Anais N., et al.
Publicado: (2023)

The urokinase receptor-derived cyclic peptide [SRSRY] suppresses neovascularization and intravasation of osteosarcoma and chondrosarcoma cells
por: Ingangi, Vincenzo, et al.
Publicado: (2016)

MicroRNAs, Long Non-Coding RNAs, and Circular RNAs in the Redox Control of Cell Senescence
por: Lettieri-Barbato, Daniele, et al.
Publicado: (2022)

microRNAs: Critical Players during Helminth Infections
por: Rojas-Pirela, Maura, et al.
Publicado: (2022)

MicroRNAs: New Players in Multiple Myeloma
por: Pichiorri, Flavia, et al.
Publicado: (2011)

MicroRNAs: Novel Players in Aortic Aneurysm
por: Fu, Xian-ming, et al.
Publicado: (2015)

Editorial: MicroRNAs as New Players in Endocrinology
por: Peng, Chun, et al.
Publicado: (2018)

MicroRNAs: New Players in the Pathobiology of Preeclampsia
por: Bounds, Kelsey R., et al.
Publicado: (2017)

MicroRNAs: emerging players in apical periodontitis
por: SHEN, Zhen, et al.
Publicado: (2021)

MicroRNAs: Emerging players in the pathogenesis of vitiligo
por: Yu, Xin, et al.
Publicado: (2022)

Effects of S-adenosyl-L-methionine on the invasion and migration of head and neck squamous cancer cells and analysis of the underlying mechanisms
por: Mosca, Laura, et al.
Publicado: (2020)

Urokinase receptor promotes ovarian cancer cell dissemination through its 84-95 sequence
por: Bifulco, Katia, et al.
Publicado: (2014)

Identification of key microRNAs of plasma extracellular vesicles and their diagnostic and prognostic significance in melanoma
por: Xiong, Jiachao, et al.
Publicado: (2020)

Serum microRNAs as biomarkers for recurrence in melanoma
por: Friedman, Erica B, et al.
Publicado: (2012)

Single Amino Acid Substitutions in the Chemotactic Sequence of Urokinase Receptor Modulate Cell Migration and Invasion
por: Bifulco, Katia, et al.
Publicado: (2012)

Involvement of the Soluble Urokinase Receptor in Chondrosarcoma Cell Mobilization
por: Bifulco, Katia, et al.
Publicado: (2011)

Sex disparity in cancer: roles of microRNAs and related functional players
por: Carè, Alessandra, et al.
Publicado: (2018)

MicroRNAs: new players in acute myeloid leukaemia
por: Havelange, V, et al.
Publicado: (2009)

Cannot write session to /tmp/vufind_sessions/sess_tb98ugum9rnl1h9720660ekib0